Literature DB >> 22116830

Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated process.

Balázs Koscsó1, Balázs Csóka, Zsolt Selmeczy, Leonóra Himer, Pál Pacher, László Virág, György Haskó.   

Abstract

Microglia are activated by pathogen-associated molecular patterns and produce proinflammatory cytokines, such as TNF-α, IL-6, and IL-12, and the anti-inflammatory cytokine IL-10. Adenosine is an endogenous purine nucleoside and a ligand of four G protein-coupled adenosine receptors (ARs), which are the A(1)AR, A(2A)AR, A(2B)AR, and A(3)AR. ARs have been shown to suppress TNF-α production by microglia, but their role in regulating IL-10 production has not been studied. In this study, we demonstrate that adenosine augments IL-10 production by activated murine microglia while suppressing the production of proinflammatory cytokines. Because the order of potency of selective AR agonists in inducing IL-10 production was NECA > IB-MECA > CCPACGS21680, and the A(2B)AR antagonist MRS1754 prevented the effect of NECA, we conclude that the stimulatory effect of adenosine on IL-10 production is mediated by the A(2B)AR. Mechanistically, adenosine augmented IL-10 mRNA accumulation by a transcriptional process. Using mutant IL-10 promoter constructs we showed that a CREB-binding region in the promoter mediated the augmenting effect of adenosine on IL-10 transcription. Chromatin immunoprecipitation analysis demonstrated that adenosine induced CREB phosphorylation at the IL-10 promoter. Silencing CREB using lentivirally delivered short hairpin RNA blocked the enhancing effect of adenosine on IL-10 production, confirming a role for CREB in mediating the stimulatory effect of adenosine on IL-10 production. In addition, adenosine augmented IL-10 production by stimulating p38 MAPK. Collectively, our results establish that A(2B)ARs augment IL-10 production by activated murine microglia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22116830      PMCID: PMC3384725          DOI: 10.4049/jimmunol.1101224

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

Review 1.  Microglial physiology: unique stimuli, specialized responses.

Authors:  Richard M Ransohoff; V Hugh Perry
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

2.  Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice.

Authors:  G Haskó; C Szabó; Z H Németh; V Kvetan; S M Pastores; E S Vizi
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

3.  Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus.

Authors:  E Blasi; R Barluzzi; V Bocchini; R Mazzolla; F Bistoni
Journal:  J Neuroimmunol       Date:  1990-05       Impact factor: 3.478

4.  Inhibition of RNA synthesis by actinomycin D: characteristic dose-response of different RNA species.

Authors:  R P Perry; D E Kelley
Journal:  J Cell Physiol       Date:  1970-10       Impact factor: 6.384

5.  Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs.

Authors:  Julie K Olson; Stephen D Miller
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

6.  Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis.

Authors:  Julia-Stefanie Frick; Christopher F MacManus; Melanie Scully; Louise E Glover; Holger K Eltzschig; Sean P Colgan
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

7.  Anti-ribosomal phosphoprotein autoantibody triggers interleukin-10 overproduction via phosphatidylinositol 3-kinase-dependent signalling pathways in lipopolysaccharide-activated macrophages.

Authors:  Tai-Ping Lee; Shr-Jeng Jim Leu; Jason C Huang; Ying-Chyi Song; Ren-Shiang Jhou; Shye-Jye Tang; Kuang-Hui Sun
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

Review 8.  Adenosine receptors: therapeutic aspects for inflammatory and immune diseases.

Authors:  György Haskó; Joel Linden; Bruce Cronstein; Pál Pacher
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

9.  Activation of cyclic-AMP response element binding protein contributes to adiponectin-stimulated interleukin-10 expression in RAW 264.7 macrophages.

Authors:  Pil-hoon Park; Honglian Huang; Megan R McMullen; Kathryn Bryan; Laura E Nagy
Journal:  J Leukoc Biol       Date:  2008-02-08       Impact factor: 4.962

10.  Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease.

Authors:  Xuesong Chen; Jeremy W Gawryluk; John F Wagener; Othman Ghribi; Jonathan D Geiger
Journal:  J Neuroinflammation       Date:  2008-04-03       Impact factor: 8.322

View more
  40 in total

1.  Combination of EPA with Carotenoids and Polyphenol Synergistically Attenuated the Transformation of Microglia to M1 Phenotype Via Inhibition of NF-κB.

Authors:  Nurit Hadad; Rachel Levy
Journal:  Neuromolecular Med       Date:  2017-08-04       Impact factor: 3.843

2.  IL-10 deficiency exacerbates the brain inflammatory response to permanent ischemia without preventing resolution of the lesion.

Authors:  Isabel Pérez-de Puig; Francesc Miró; Angélica Salas-Perdomo; Ester Bonfill-Teixidor; Maura Ferrer-Ferrer; Leonardo Márquez-Kisinousky; Anna M Planas
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-11       Impact factor: 6.200

3.  CD73-generated adenosine is critical for immune regulation during Toxoplasma gondii infection.

Authors:  Deeqa A Mahamed; Leon E Toussaint; Margaret S Bynoe
Journal:  Infect Immun       Date:  2014-12-01       Impact factor: 3.441

4.  Microglial phenotypes in the human epileptic temporal lobe.

Authors:  Mélanie Morin-Brureau; Giampaolo Milior; Juliette Royer; Farah Chali; Caroline Le Duigou; Etienne Savary; Corinne Blugeon; Laurent Jourdren; David Akbar; Sophie Dupont; Vincent Navarro; Michel Baulac; Franck Bielle; Bertrand Mathon; Stéphane Clemenceau; Richard Miles
Journal:  Brain       Date:  2018-12-01       Impact factor: 13.501

Review 5.  The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.

Authors:  Elham Safarzadeh; Farhad Jadidi-Niaragh; Morteza Motallebnezhad; Mehdi Yousefi
Journal:  Inflamm Res       Date:  2016-03-09       Impact factor: 4.575

6.  Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages.

Authors:  Balázs Koscsó; Balázs Csóka; Endre Kókai; Zoltán H Németh; Pál Pacher; László Virág; S Joseph Leibovich; György Haskó
Journal:  J Leukoc Biol       Date:  2013-08-06       Impact factor: 4.962

Review 7.  Targeting of G-protein coupled receptors in sepsis.

Authors:  Abdul Rehman; Noor Ul-Ain Baloch; John P Morrow; Pál Pacher; György Haskó
Journal:  Pharmacol Ther       Date:  2020-03-19       Impact factor: 12.310

8.  β-Arrestin 2 negatively regulates Toll-like receptor 4 (TLR4)-triggered inflammatory signaling via targeting p38 MAPK and interleukin 10.

Authors:  Hui Li; Dan Hu; Huimin Fan; Ying Zhang; Gene D LeSage; Yi Caudle; Charles Stuart; Zhongmin Liu; Deling Yin
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

9.  Intrathecal injection of adenosine 2A receptor agonists reversed neuropathic allodynia through protein kinase (PK)A/PKC signaling.

Authors:  Lisa C Loram; Frederick R Taylor; Keith A Strand; Jacqueline A Harrison; Rachael Rzasalynn; Paige Sholar; Jayson Rieger; Steven F Maier; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2013-06-28       Impact factor: 7.217

10.  Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin-10 production.

Authors:  Isha Dhande; Wanshu Ma; Tahir Hussain
Journal:  Hypertens Res       Date:  2014-09-11       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.